Affect of Age on Out of Pocket Health Expenditures for Breast Cancer Survivors by Cole, Carson
1 
 
Affect of Age on Out of Pocket Health Expenditures for Breast Cancer Survivors 
 





Medical non-adherence in breast cancer survivors can be attributed to out-of-pocket (OOP) expenditures. 
A cancer survivor is defined as anyone who has been diagnosed with cancer and is still living. 
Some prominent variables that affect OOP spending are income, age, weight, ethnicity, etc. The 
relationship between OOP spending and these variables will be examined using a variety of multi linear 
regression analysis and their supporting tests. Discovering variables that help us understand why certain  
survivors pay more per year on health are valuable because we may then be more aware of when a 























I. Introduction  
Catastrophic health expenditures correlate with medication nonadherence and medication cost-coping 
strategies. WHO defines health expenditures as catastrophic when one spends more than 40% of their 
non-subsistence income on health services. One participates in medication non-adherence they do not 
seek and use medical services properly. Medication cost-coping strategies can range from borrowing 
money to selling medication to alleviate costs to not purchasing the medication at all.  
 
1 in 8 American women will be diagnosed with breast cancer and the frequency has been increasing 
(Short et al 2010). Pisu et al (2014) estimate that OOP costs range between $300 and $1,180 per month in 
the first year of treatment and $500 afterwards. While these numbers do not guarantee catastrophic 
spending, many will face the decision of whether to seek proper medical treatment. Breast cancer patients 
over the age of 75 have shown to more likely to be medically non adherent (Zullig et al 2013). While 
there are multiple hypotheses around this, one thought is that elderly individuals do not believe the costs 
to be worth it given their limited time left. Supporting, Allaire et al (2017) found that OOP was higher for 
woman under the age of 45. They concluded that further research needs to be held to discover why this is. 
These two points would suggest that OOP spending is higher for younger adults, potentially because 
elderly patients are more likely to be medically non-adherent. 
 
A 2013 study from Zullig et al found that breast cancer patients with higher OOP costs for their 
aromatase inhibitors were more likely to be non-adherent with their medication as opposed to patients 
with lower OOP costs. They also found that patients with higher costs were also more likely to abandon 
their oral chemotherapy prescriptions which increased their probability of mortality.  
 
This information motivates research in the study of variables that affect OOP expenditures for breast 
cancer patients. Patients who coincide with these variables may be deemed more susceptible to medical 
non-adherence and could benefit from additional monitoring and briefing .  
 
Hypothesis 
Out-of-pocket spending for breast cancer patients will be the dependent variable. Age is the primary 
independent variable. Younger persons may put a higher value on their health and thus be more willing to 
pay more to maintain their health. Older persons may view these treatments as having a diminishing 
return on extending the years until they pass. A person, say 85, may not think it worth to pay $16,910 in 
the initial year of treatment (average OOP expenditure during the first year according to Short et al  
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2010). Instead they may believe their spouse, children, or organization could reap better benefits from this 
money. Hypothetically, OOP expenditures and age will have an inverse relationship. A higher age will 
result in lower OOP spending. 
 
This hypothesis will be used to test each variable 
H0 : βk = 0 
H1 : βk ≠ 0 
Where Bk represents any of the independent variables. A two tailed t-test will be used to test the 
significance. 
 
II. Literature Review 
A study to estimate national OOP medical expenditures for cancer survivors whose age was less than 65 
was conducted by Short et al in  2010. This study only analyzed those under the age of 65 because the 
majority of those above that age are under Medicare and should be viewed in a separate analysis. Data 
from 2001 to 2007 was gathered from the Medical Expenditure Panel Survey (MEPS) and the National 
Health Interview Survey (NHIS). Propensity score matching was used to estimate the relationship 
between cancer and OOP expenditures. Probit models were developed to estimate the probability of 
exceeding various expenditure thresholds. Short et al found that the average annual OOP expenditures for 
cancer survivors was $16,910 for those who had been diagnosed that year and $7992 for those diagnosed 
in previous years. The average for all survivors was approximately $9300. The authors found this study to 
be of importance for a few reasons. Cancer diagnoses have increased from 6 to 12 million in the past 20 
years. These individuals who are given diagnosis have higher life expectancies due to advancements in 
treatment, and they are bringing into question the long term effects of these treatments and whether or not 
they are worth it. Cancer has been treated with increased combinations of higher doses across a wide 
range of medical procedures such as radiation, hormone, and chemo therapies. Potential long term 
consequences of treatment have shown to be “impaired physical and organ function, changes in 
appearance, sexual dysfunction, incontinence, lymphedema, hormone imbalances, cognitive difficulties, 
and fatigue.”  
 
Kaisaeng et al (2014) conducted a cross-sectional random sample study of 5% of Medicare beneficiaries 
who were prescribed imatinib, erlotinib, anastrozole, letrozole, or thalidomide to treat their oral cancer in 
2008. Discontinuation or delay of medication was measured against OOP expenditures using logistic 
regression. The patients studied in the sample did not receive subsidies for their medication and were 
aged 65 or older. OOP costs for medication ranged from $2.96-$37.47 per day depending on the 
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medication. The study found that an increase in OOP costs resulted in an increase chance that the 
individual discontinued or delayed their medication. Variables included in their analysis included age, 
sex, Caucasian (binary), number of comorbidities, number of non cancer drugs, beneficiaries with 
enhanced alternative benefit, and cost of non cancer drugs. Medication delay was defined as going 30 
days or more “between the date that the patient’s supply of the medication should have expired and the 
date that the patient obtained the next refill” Discontinuation was defined as a patient being without 
medication for more than 30 days. Overall, this paper finds that increases in OOP spending increases the 
probability that an oral cancer patient will be medically non-adherent with their medications. 
 
Bernard et al conducted a study in 2011 using NHIS data from 2001-2009. They compared the ratio of 
OOP expenditures and income for adults between the ages of 18 and 64 who received treatment for 
cancer. They then looked at the proportion of these patients who lived in lived in high health burden 
households. They defined a high health burden as spending more than 20% of income on health related 
services. They found that 13.4% of these cancer patients had high health burdens while 9.7% of other 
chronic illness patients did, and 4.4% of those without chronic illnesses experienced this. Among those 
under the age of 65 without cancer, they found the highest correlation between high health burdens and 
age “55-64, non-Hispanic black, never married or widowed, one child or no children, unemployed, lower 
income, lower education level, living in nonmetropolitan statistical areas, and having other chronic 
conditions.” They then categorized the patients by age in groups of 18-39, 40-54, and 55-64. They found 
that older age groups were more likely to experience high health burdens. They also categorized based on 
whether they were insured with a private group, private nongroup, public, or uninsured. They found 
private groups had the lowest chance of being in a high health burden household while private non-groups 
had the highest. 
  
To the best of my knowledge, no other paper has used 2019 NHIS data to examine the effect of age on 
OOP health spending across all age groups instead of being split at the age of 65. I will conduct a chow 
test to see if an MLR may be able to pool both age groups, those under and over 65. My hope is that this 
contributes to the understanding of how age affects OOP spending. If it does, then older or younger breast 
cancer patients with more or less time passed since their diagnosis may need to be given additional 







III. Data  
Variables are included in this analysis for the following reasons. Employment and family income were 
found to be significant factors affecting OOP spending according to Rashidul et al (2017). Insurance 
coverage was found to impact OOP spending in Bernard et al (2014). Hispanic ethnicity is included 
because Bustamante et al (2011) found those of Hispanic ethnicity had lower OOP. Obesity leads to a 
number of health risks and thus weight is included. Medicare coverage is included because there is a drop 
off in OOP at the age of 65 and this is likely due to Medicare coverage. GTE65 is also included to 
conduct the chow test. GTE65 and Medicare could likely be used interchangeably, but both will be used 
in separate analysis for specific purposes. 
 
Table.1 Variable Discriptions 
Variable Name Description Type of Values 
Ln(FAMINCTC_A) Natural log of family income Integer ($) 
AGEP_A Age Integer 
WEIGHTLBTC_A Weight Integer 
HISP_A Hispanic ethnicity 1 or 0 
NOTCOV_A Has health insurance 1 or 0 
EMPWRKLSWK_A Worked last week 1 or 0 
HICOSTR1_A Out-of-pocket health expenditures Integer ($) 
medicare Has Medicare insurance 1 or 0 
GTE65 Age greater than are equal to 65 1 or 0 
 
Source 
The source of the data is the 2019 CDC National Health Interview Survey. The original sample size was 
31,997. Responses coded as “Refused to answer”, “Does not know”, or similar have been dropped from 
the data.  Observations were dropped for those who had not had breast cancer. The sample size used in 
this study is 272. The variable ln(FAMINCTC_A) was created from FAMINCTC_A. GTE65 is a binary 
variable created from AGEP_A where survivors were coded as 1 for being 65 or older and 0 for younger. 
 







    Table.2 Variable summary 
Variable Obs Mean STD Min Max 
HICOSTR1_A 272 3,709.48 4,336.41 1 40,000 
FAMINCTC_A 272 62,432.98 51,492.52 3,000 220,000 
ln(FAMINCTC_A) 272 10.72 0.83  8.01 12.301 
AGEP_A 272 69.48 11.60 23 85 
WEIGHTLBTC_A 272 163.59 33.17 100 270 
HISP_A 272 0.07 0.26 0 1 
NOTCOV_A 272 0.02 0.13 0 1 
EMPWRKLSWK_A 272 0.71 0.45 0 1 




Here, the six classic linear model assumptions will be examined to determine whether we may carry on to 
forming valid regressions. 
 
MLR.1: Model is linear in its parameters. We might be able to predict OOPSpending given 
these variables which are linear parameters. Each parameter is linear because the degree of its 
polynomial is 1. The 𝑢 represents the error term.  
 
HICOSTR1_A = 𝛽1𝑙𝑛(𝐹𝐴𝑀𝐼𝑁𝐶𝑇𝐶_𝐴) + 𝛽2(𝐴𝐺𝐸𝑃_𝐴) +  𝛽3(𝑊𝐸𝐼𝐺𝐻𝑇𝐿𝐵𝑇𝐶_𝐴) +
 𝛽4 (𝐻𝐼𝑆𝑃_𝐴) + 𝛽5(𝐸𝑀𝑃𝑊𝑅𝐾𝐿𝑆𝑊𝐾_𝐴) + 𝛽6(𝑚𝑒𝑑𝑖𝑐𝑎𝑟𝑒) + 𝑢 
 
MLR.2: Data is gathered using random sampling. The data is gathered using geographically 
clustered sampling, so it is not completely random and observations are not independent of each 
other. Although, the sample has been obtained in a manner that the CDC believes to be 
representative of the nation. Also, the mean age of this sample is 69, far above the average US 
citizen age of 38. Even still, this analysis may still produce a useful conclusion. 
 
Table.2 Regions from which participants lived  
Region Northeast Midwest South West 




MLR.3: No perfect collinearity. During the regression, NOTCOV_A (whether or not someone 
had health insurance) was found to have an issue with collinearity due to almost all participants 
having health insurance. In order to maintain the integrity of the regressions, NOTCOV_A has 
been committed.  After reviewing the correlation table, STATA.2, we can see that none of the 
other variables are linear combinations of each other, nor do they demonstrate prefect 
collinearity. A high correlation was found between AGEP_A and medicare due to medicare only 
being available to those who are 65 and older. This will provide an issue with multi collinearity 
when performing the Chow test. Thus, the variable medicare will be removed for the Chow test. 
We can also see that the variance inflation factor (VIF) is relatively low for all of the variables 
with the highest being 3.01 for AGEP_A. AGEP_A is thought to have multi-collinearity with the 
presence of medicare and lack of employment; a relationship which will be examined in the 
regressions. 
 
MLR.4: Zero Conditional Mean. There is a chance of misspecification in the MLR. A variable 
such as height has been shown to have effects on health, but it is not being used in this analysis 
due to its low impact. If height were to be included it would have a correlation with weight such 
that δ1 != 0 Thus, we cannot guarantee that E(U|x ) != 0. In image.1 , we can see that the average 
residual hovers slightly above 0 and does not change as the fitted values increase. Thus, the 
MLR.4 assumption is relatively strong even though we are not accounting for all variables that 
could be potentially affecting HICOSTR1_A. 
 





MLR.5: Homoskedasticity. There could be a term in U that has a change in variation depending 
on the value of x, so we cannot be certain that MLR.5 is true. We can see that the residuals grow 
larger as the fitted values increase. This is a signal that heteroskedasticity may be present in the 
data. The breusch-pagan test in STATA.3 confirmed heteroskedasticity with a p-value <  1%. 
Thus, MLR.5 is violated and we cannot assume that the residuals do not vary with x.  
 
MLR.6: Normality. Because there are many unobserved variables in the U term affecting Y, we 
could assume that U has a normal distribution due to the central limit theorem. We prove this 
further by plotting a histogram in figure.2  that shows that the residuals have an approximately 
normal distribution with a slight positive skew. This implies that y is also following an 
approximately normal distribution.  
 








III. Results  
After reviewing the CLM’s, we can conclude that not all of them are perfectly satisfied. Although, 
constructing regressions and performing tests on this data may still prove useful. 
 
Simple Linear Regression Model 
HICOSTR1_A = 9165.07  -  79.80(AGEP_A) + u 
 
From the model in STATA.4, for every year a recipient aged, on average, their OOP expenditures would 
decrease by $79.80. A 25 year old would be expected to spend $7170, while someone who was 85 would 
be expected to spend $2382. The coefficient of the AGEP_A variable is significant at <1%. This aligns 
with the prediction that older persons are likely to spend less on OOP health and the literature cited 
above. This regression produces an R-square value of 0.0484 which motivates a multi linear regression in 





Multi Linear Regression Model 1 
HICOSTR1_A =  5960.25  -  12.75(AGEP_A)  +  1144.90ln(FAMINCTC_A)   -  
16.72(WEIGHTLBTC_A)  +  2041.12(HISP_A)  -  891.60(EMPWRKLSWK_A)  -  1172.90(medicare)  
+  u 
From STATA.5: Similarly to the SLR, we see that an increase in age decreases OOP spending but by 
significantly less. Furthermore, age is now nowhere close to being significant. For every 1% increase in 
family income, OOP increased by about $11.45 with significance at 1%. Weight has an inverse 
relationship where for every pound added to weight, they spend $16.71 less with significance at 5%. Not 
having Hispanic ethnicity increased OOP by $2041.12, significant at 10%. Having worked the previous 
week was not significant and neither was having medicare. This produces an R-squared value of .1387, 
marginally better than our SLR model. This indicates that there are other variables other than the ones in 
this MLR that could better account for the variability in a person’s OOP. 
 
Multi Linear Regression Model 2 
HICOSTR1_A =  -4686.11  -  71.91(AGEP_A)  +  1287.66ln(FAMINCTC_A)   -  
17.17(WEIGHTLBTC_A)  +  2055.40(HISP_A)  +  u 
 
From STATA.6: After dropping employment and medicare, the insignificant variables, we see similar 
coefficients and significance levels for all variables except a persons age. Age jumps to a similar 
significance and coefficient as we saw in the SLR. As individuals age they are less likely to work and 
more likely to have medicare. This leads to the belief that dropping the medicare and employment 
variables between MLR1 and MLR2 are likely what caused age to become significant with a large 
coefficient due to multi-collinearity between these three variables.  
 
Multi Linear Regression Model 3 
HICOSTR1_A =  5232.7  +  2.03(AGEP_A)  -  956.89(EMPWRKLSWK_A)  -  1752.91(medicare)  +  u 
 
From STATA.7: We now wish to look at the regression with age along with the two variables it is 
believed to have multicollinearity with, employment and medicare. We now see that age becomes entirely 
insignifigant. Employment did not become signifigant while medicare became signifigant at 5%. In this 
model, if one has medicare they are expected to spend $1752.91 less on OOP. We could conclude that of 




Multi Linear Regression Model 4 
HICOSTR1_A =  5875.60.  -  12.31(AGEP_A)  -  2131.87(medicare)  +  u 
 
From STATA.8: After removing the insignifigant variable in the last model, employment, age still 
remains insignifigant. On the other hand, medicare now reaches signifigance of 1% with an increased 
coefficient. In this model, medicare patients are expected to spend $2131.87 less on OOP health 
expenditures. We still conclude that medicare status is a better predictor for OOP than age. 
 
           Table.3 Regression Table, Coefficients, and Signifigance 
Independent 
Variables 
SLR MLR1 MLR2 MLR3 MLR4 






































Intercept  9165.07 -5960.25 -4686.105 5232.7 5875.60 
R^2 0.0484 0.1387 0.1227 .0766 0.0709 
Adj. R^2 0.0449 0.1192 0.1095 .0663 0.0639 
*10%, **5%, ***1% signifigance 
 
           Table.4 MLR1 Variable Output  Details 
Variable Coefficient t-value p-value 95% CI 
FAMINCTC_A 1144.90 3.01 0.003 (396.34, 1893.47) 
AGEP_A -12.74 
 





7.62 -2.20 (-31.74, -1.73) 
HISP_A -2041.12 
 
-1.85 0.07 (-4216.15, 133.92) 
EMPWRKLSWK_A -891.60 
 
-1.23 0.220 (-2319.95, 536.74) 
medicare -1172.90 -1.35 0.179 (-2886.27, 540.48) 
 
IV. Extensions  
 
Chow Test 
            Figure.3 Visualization of OOP Regressed on Age 
 
 
In Figure.3, we notice a decline in the amount of OOP and its variability once persons cross the age of 65. 
It also seems as though with a higher ages comes higher OOP with a drop at 65 and then a small increase 
in OOP as age continues to progress. This is contrary to the belief that with higher age comes lower OOP. 
This is believed to be attributed to medicare becoming available at this age. Two regressions will be ran 
and then used in a chow test to see if they can be pooled together. The first regression will be the MLR1 
of participants aged 65 and older, while the second regression will be MLR1 of those under 65. 
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The pooled regression will be MLR1. We are interested in if the split regressions can be represented or 
‘pooled’ by the pooled regression. All three of these MLRs will have a common deviation from MLR1. 
Since Age and medicare have such a high correlation (.7272), the medicare variable will be dropped from 
each regression.  
 
*Note: the Chow test is only valid under the assumption of homoscedasticity. Even though we found 
heteroskedasticity in the brusch-pagan test, we will still run the chow test and interpret the results as if 
homoskedasticity was present. 
 
H0 : We cannot pool all age groups into a regression 




HICOSTR1_A =  -2840.36   –   41.19(AGEP_A)  +  1190.97ln(FAMINCTC_A)   -  
17.80(WEIGHTLBTC_A)  +  2119.54(HISP_A)  -  1208.54(EMPWRKLSWK_A)  +  u 
 
From STATA.9: After dropping medicare from MLR1, the only notable change is that employment 
becomes signifigant at 10% and indicates that if someone worked in the past week, they will spend 
1208.54 less on OOP on average. 
 
MLR.Chow. >= 65 
HICOSTR1_A =  -2961.44   –   16.24(AGEP_A)  +  577.12ln(FAMINCTC_A)   -  
6.25(WEIGHTLBTC_A)  +  676.13(HISP_A)  -  853.79(EMPWRKLSWK_A)  +  u 
From STATA.10: We see all variables lose signifigance in this model. 
 
MLR.Chow. < 65 
HICOSTR1_A =  -20029.53   –   43.67(AGEP_A)  +  2511.77ln(FAMINCTC_A)   -  
30.13(WEIGHTLBTC_A)  +  2434.29(HISP_A)  -  518.83(EMPWRKLSWK_A)  +  u 
 
From STATA.11: Both ln(income) and weight remain at their signifigance levels of 1% and 5% 
respectively, but now their coefficients have doubled. For every 1% increase in income a person is 
expected to spend $25 less on OOP and for every pound gained, a person is expected to spend $30 less on 





The Chow value was then computed using the following equation. 
 
𝐶ℎ𝑜𝑤 =  
[𝑆𝑆𝑅𝑝𝑜𝑜𝑙  −  (𝑆𝑆𝑅𝑜𝑣𝑒𝑟65  +  𝑆𝑆𝑅𝑢𝑛𝑑𝑒𝑟65)
𝑆𝑆𝑅𝑜𝑣𝑒𝑟65 +  𝑆𝑆𝑅𝑢𝑛𝑑𝑒𝑟65
 ∙  
𝑛−2(𝑘+1)
(𝑘+1)
  =  2.66 
 
Using degrees of freedom 5 and 266 for the numerator and denominator respectively, we find 
this result to be significant at 5%. Thus, we reject the null hypothesis with 95% confidence and 
conclude that the pooled regression is sufficiently representative for those under and greater than 
or equal to the age of 65. 
 
    Table.5 Chow Test Coefficients, and Significance 
Independent 
Variables 

































Intercept  -2840.36 -2961.44 -20029.53 
R^2 0.1327 0.0339 0.1478 
Adj. R^2 0.1164 0.0057 0.0999 








V. Conclusions  
 
The chow test had two purposes. Previous studies have conducted analysis either over or under the age of 
65 because they believe that the two age groups cannot be represented by one MLR. Thus one purpose 
whether or this was true. The reasoning behind the splitting is that there is a belief that there will be a 
signifigant difference in OOP health expenditures based on whether you are over or under the age of 65, 
attributed to medicare availability. Thus the other purpose was to see if the coefficients for age in the split 
groups differed signifigantly from the pooled MLR. Although the coefficients for age in the pool were 
negative and positive for both splits, the age coefficient in the pooled was significant while neither split 
age groups yielded remotely signifigatn coefficients for age. Therefore, we can reject the null hypothesis 
(as thought in Bernard et al 2011) that have the thought that both age groups cannot be pooled. Although, 
this rejection is expected to have an increased type 1 error due to the fact that not all MLRs could be 
assumed. Specifically, MLR.5 could not be assumed due to the presence of heteroskedasticity as 
determined by the brusch-pagan test. Thus, this rejection should not be taken on concrete grounds. 
 
Now that we have established the relationship between age, OOP, and age groups split at 65, we can 
discuss our original hypothesis as to whether age is a signifigantly signifigant factor in a breast cancer 
survivor’s annual out-of-pocket health expenditure. According to the pooled model used in the chow test, 
age is a signifigant factor. Thus, we reject the null hypothesis that age is not a signifigant factor in a 
survivors OOP. 
 
One variable that would have been interesting to see is if one became medically non-adherent. At first 
thought, one would believe the presence of this variable would drastically drop OOP health expenditures, 
but I believe the relationship would be more complex. Being medically non adherent for one medical 
procedure does not mean you are medically nonadherent for all. You may be okay with pills but don’t 
want to go through radiation. Another such as whether one became medically non would have been useful 
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STATA.1 Variance Inflation Factor 
 
 
STATA.2 Corelation Coefficients 
 
 




    Mean VIF        1.89
                                    
      HISP_A        1.04    0.957742
WEIGHTLBTC_A        1.11    0.903108
lnFAMINCTC_A        1.19    0.839176
EMPWRKLSWK_A        2.08    0.481862
    medicare        2.93    0.341802
      AGEP_A        3.01    0.332041
                                    
    Variable         VIF       1/VIF  
    medicare    -0.2653  -0.3498  -0.1172   0.1102   0.7787   0.6763   1.0000
EMPWRKLSWK_A    -0.2374  -0.3232  -0.1703   0.1311   0.6703   1.0000
      AGEP_A    -0.2200  -0.3375  -0.2304   0.1681   1.0000
      HISP_A     0.0599  -0.0375   0.0538   1.0000
WEIGHTLBTC_A    -0.0969  -0.0625   1.0000
lnFAMINCTC_A     0.2821   1.0000
  HICOSTR1_A     1.0000
                                                                             
               HICO~1_A lnFAMI~A WEIGHT~A   HISP_A   AGEP_A EMPW~K_A medicare
Prob > chi2 = 0.0000
    chi2(1) = 126.09
H0: Constant variance
Variable: Fitted values of HICOSTR1_A
Assumption: Normal error terms
















       _cons     9165.073   1494.665     6.13   0.000     6222.393    12107.75
      AGEP_A    -79.79775   21.53665    -3.71   0.000    -122.1989   -37.39663
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    5.0960e+09       271  18804490.1   Root MSE        =      4238
                                                   Adj R-squared   =    0.0449
    Residual    4.8494e+09       270  17960887.6   R-squared       =    0.0484
       Model     246577182         1   246577182   Prob > F        =    0.0003
                                                   F(1, 270)       =     13.73
      Source         SS           df       MS      Number of obs   =       272
. regress HICOSTR1_A AGEP_A
                                                                              
       _cons    -3919.131   5390.166    -0.73   0.468    -14532.13     6693.87
    medicare    -1172.896   870.1948    -1.35   0.179    -2886.271    540.4795
EMPWRKLSWK_A    -891.6026   725.4337    -1.23   0.220     -2319.95    536.7447
      AGEP_A    -12.74768   35.89219    -0.36   0.723    -83.41784    57.92249
      HISP_A    -2041.117   1104.662    -1.85   0.066    -4216.149    133.9152
WEIGHTLBTC_A    -16.71998   7.615388    -2.20   0.029    -31.71434   -1.725613
lnFAMINCTC_A     1144.904   380.1844     3.01   0.003     396.3371     1893.47
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    5.0960e+09       271  18804490.1   Root MSE        =    4069.9
                                                   Adj R-squared   =    0.1192
    Residual    4.3894e+09       265  16563921.9   R-squared       =    0.1387
       Model     706577521         6   117762920   Prob > F        =    0.0000
                                                   F(6, 265)       =      7.11
      Source         SS           df       MS      Number of obs   =       272
       _cons    -2630.703   5358.124    -0.49   0.624    -13180.25    7918.846
      AGEP_A    -71.90678    23.3357    -3.08   0.002    -117.8522   -25.96138
      HISP_A    -2055.401   1108.536    -1.85   0.065    -4237.984    127.1819
WEIGHTLBTC_A    -17.17192   7.605725    -2.26   0.025    -32.14675   -2.197097
lnFAMINCTC_A     1287.664   376.6844     3.42   0.001     546.0142    2029.314
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    5.0960e+09       271  18804490.1   Root MSE        =    4092.1
                                                   Adj R-squared   =    0.1095
    Residual    4.4709e+09       267  16744942.6   R-squared       =    0.1227
       Model     625117138         4   156279284   Prob > F        =    0.0000
                                                   F(4, 267)       =      9.33













       _cons       5232.7    2022.65     2.59   0.010     1250.395    9215.005
    medicare    -1752.913   884.9135    -1.98   0.049    -3495.179   -10.64606
EMPWRKLSWK_A    -956.8867   740.5141    -1.29   0.197    -2414.852    501.0784
      AGEP_A     2.038146   35.71126     0.06   0.955    -68.27215    72.34844
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    5.0960e+09       271  18804490.1   Root MSE        =    4190.3
                                                   Adj R-squared   =    0.0663
    Residual    4.7056e+09       268    17558366   R-squared       =    0.0766
       Model     390374743         3   130124914   Prob > F        =    0.0001
                                                   F(3, 268)       =      7.41
      Source         SS           df       MS      Number of obs   =       272
       _cons     5875.603   1962.944     2.99   0.003     2010.917     9740.29
    medicare    -2131.864   835.9455    -2.55   0.011    -3777.692   -486.0356
      AGEP_A      -12.309   33.98362    -0.36   0.717    -79.21671     54.5987
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    5.0960e+09       271  18804490.1   Root MSE        =    4195.5
                                                   Adj R-squared   =    0.0639
    Residual    4.7350e+09       269  17602083.1   R-squared       =    0.0709
       Model     361056466         2   180528233   Prob > F        =    0.0001
                                                   F(2, 269)       =     10.26
      Source         SS           df       MS      Number of obs   =       272
       _cons    -2840.355    5338.59    -0.53   0.595    -13351.62    7670.914
EMPWRKLSWK_A    -1208.538   687.3202    -1.76   0.080    -2561.818    144.7421
      AGEP_A    -41.19429   29.07597    -1.42   0.158    -98.44261    16.05403
      HISP_A    -2119.544   1104.821    -1.92   0.056    -4294.851    55.76334
WEIGHTLBTC_A    -17.80198   7.584576    -2.35   0.020    -32.73542   -2.868539
lnFAMINCTC_A     1190.968   379.2261     3.14   0.002     444.3008    1937.634
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    5.0960e+09       271  18804490.1   Root MSE        =    4076.1
                                                   Adj R-squared   =    0.1164
    Residual    4.4195e+09       266  16614778.9   R-squared       =    0.1327
       Model     676485648         5   135297130   Prob > F        =    0.0000
                                                   F(5, 266)       =      8.14








       _cons    -2961.437   5661.213    -0.52   0.602     -14136.3    8213.423
EMPWRKLSWK_A    -853.7937   686.0436    -1.24   0.215    -2207.998    500.4111
      AGEP_A     16.24089   41.91142     0.39   0.699     -66.4895    98.97127
      HISP_A     -676.126   1325.414    -0.51   0.611    -3292.406    1940.154
WEIGHTLBTC_A     -6.24771   7.932037    -0.79   0.432    -21.90503    9.409607
lnFAMINCTC_A     577.1158   353.7139     1.63   0.105    -121.0922    1275.324
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    1.7649e+09       176  10027658.3   Root MSE        =    3157.7
                                                   Adj R-squared   =    0.0057
    Residual    1.7050e+09       171  9970894.89   R-squared       =    0.0339
       Model    59844843.2         5  11968968.6   Prob > F        =    0.3111
                                                   F(5, 171)       =      1.20
      Source         SS           df       MS      Number of obs   =       177
       _cons    -20029.53   12254.65    -1.63   0.106    -44379.27    4320.205
EMPWRKLSWK_A    -518.8264    1547.81    -0.34   0.738    -3594.293     2556.64
      AGEP_A     43.67009   75.36412     0.58   0.564    -106.0768     193.417
      HISP_A    -2434.291   1913.053    -1.27   0.207    -6235.486    1366.905
WEIGHTLBTC_A    -30.13009   14.89164    -2.02   0.046    -59.71946   -.5407178
lnFAMINCTC_A     2511.767   911.6924     2.76   0.007     700.2531     4323.28
                                                                              
  HICOSTR1_A   Coefficient  Std. err.      t    P>|t|     [95% conf. interval]
                                                                              
       Total    2.8852e+09        94  30693679.6   Root MSE        =    5256.1
                                                   Adj R-squared   =    0.0999
    Residual    2.4588e+09        89  27627107.2   R-squared       =    0.1478
       Model     426393340         5  85278668.1   Prob > F        =    0.0129
                                                   F(5, 89)        =      3.09
      Source         SS           df       MS      Number of obs   =        95
